|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000173705 |
Summary for SUSD5 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000173705 | Gene symbol | SUSD5 |
| Gene name | sushi domain containing 5 | |
| HGNC | 29061 | |
| Entrez ID | 26032 | |
| Gene type | protein_coding | |
| Synonyms | SUSD5|KIAA0527 | |
| UniProtAcc | O60279 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for SUSD5 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for SUSD5 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for SUSD5 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg07008600 | chr3:33219712 | CGI:chr3:33218427-33219271 | promoter | 6.64e-01 | 7.78e-01 | -2.34e+00 | 1.93e-02 | 3.44e-02 | -1.15e-01 |
| CHOL | cg04545136 | chr3:33219240 | CGI:chr3:33218427-33219271 | promoter | 3.07e-01 | 4.77e-01 | -2.39e+00 | 1.70e-02 | 2.98e-02 | -1.70e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg02239862 | chr3:33219251 | CGI:chr3:33218427-33219271 | promoter | 2.36e-01 | 1.21e-01 | 4.67e+00 | 3.00e-06 | 9.46e-06 | 1.15e-01 |
| KIRC | cg03497399 | chr3:33219442 | CGI:chr3:33218427-33219271 | promoter | 5.06e-01 | 3.90e-01 | 2.58e+00 | 9.91e-03 | 1.18e-02 | 1.16e-01 |
| LUAD | cg02239862 | chr3:33219251 | CGI:chr3:33218427-33219271 | promoter | 2.33e-01 | 1.27e-01 | 3.46e+00 | 5.46e-04 | 1.17e-03 | 1.06e-01 |
| HNSC | cg04545136 | chr3:33219240 | CGI:chr3:33218427-33219271 | promoter | 2.84e-01 | 9.76e-02 | 4.30e+00 | 1.73e-05 | 5.99e-05 | 1.86e-01 |
| HNSC | cg03497399 | chr3:33219442 | CGI:chr3:33218427-33219271 | promoter | 6.51e-01 | 5.17e-01 | 4.19e+00 | 2.85e-05 | 9.05e-05 | 1.34e-01 |
| HNSC | cg25693769 | chr3:33219620 | CGI:chr3:33218427-33219271 | promoter | 7.18e-01 | 5.89e-01 | 4.53e+00 | 5.96e-06 | 2.48e-05 | 1.29e-01 |
| LUSC | cg03497399 | chr3:33219442 | CGI:chr3:33218427-33219271 | promoter | 6.44e-01 | 4.44e-01 | 3.73e+00 | 1.91e-04 | 9.47e-04 | 2.00e-01 |
| LUSC | cg25693769 | chr3:33219620 | CGI:chr3:33218427-33219271 | promoter | 7.19e-01 | 5.59e-01 | 3.77e+00 | 1.61e-04 | 8.69e-04 | 1.60e-01 |
| BLCA | cg13601427 | chr3:33219260 | CGI:chr3:33218427-33219271 | promoter | 1.65e-01 | 3.32e-02 | 2.22e+00 | 2.63e-02 | 3.03e-02 | 1.31e-01 |
| BLCA | cg09463233 | chr3:33218874 | CGI:chr3:33218427-33219271 | UTR,promoter,exon,gene body | 1.85e-01 | 6.19e-02 | 2.20e+00 | 2.78e-02 | 3.17e-02 | 1.24e-01 |
| BLCA | cg04545136 | chr3:33219240 | CGI:chr3:33218427-33219271 | promoter | 2.66e-01 | 9.77e-02 | 2.22e+00 | 2.65e-02 | 3.05e-02 | 1.69e-01 |
| BLCA | cg02239862 | chr3:33219251 | CGI:chr3:33218427-33219271 | promoter | 3.19e-01 | 1.30e-01 | 2.74e+00 | 6.08e-03 | 9.51e-03 | 1.90e-01 |
| BLCA | cg07008600 | chr3:33219712 | CGI:chr3:33218427-33219271 | promoter | 5.11e-01 | 6.42e-01 | -2.09e+00 | 3.65e-02 | 3.91e-02 | -1.31e-01 |
| CHOL | cg13601427 | chr3:33219260 | CGI:chr3:33218427-33219271 | promoter | 2.86e-01 | 5.10e-02 | 3.02e+00 | 2.51e-03 | 1.19e-02 | 2.35e-01 |
| CHOL | cg26298814 | chr3:33218397 | CGI:chr3:33218427-33219271 | promoter,gene body | 2.11e-01 | 5.76e-02 | 3.10e+00 | 1.96e-03 | 1.07e-02 | 1.53e-01 |
| CHOL | cg10906602 | chr3:33218428 | CGI:chr3:33218427-33219271 | promoter,gene body | 3.00e-01 | 9.09e-02 | 2.80e+00 | 5.09e-03 | 1.63e-02 | 2.09e-01 |
| CHOL | cg04545136 | chr3:33219240 | CGI:chr3:33218427-33219271 | promoter | 4.77e-01 | 1.16e-01 | 3.17e+00 | 1.52e-03 | 1.07e-02 | 3.61e-01 |
| CHOL | cg02239862 | chr3:33219251 | CGI:chr3:33218427-33219271 | promoter | 5.35e-01 | 1.74e-01 | 3.39e+00 | 6.96e-04 | 9.20e-03 | 3.61e-01 |
| CHOL | cg03497399 | chr3:33219442 | CGI:chr3:33218427-33219271 | promoter | 5.91e-01 | 3.30e-01 | 3.10e+00 | 1.96e-03 | 1.07e-02 | 2.61e-01 |
| CHOL | cg13747145 | chr3:33219508 | CGI:chr3:33218427-33219271 | promoter | 8.29e-01 | 6.77e-01 | 3.39e+00 | 6.96e-04 | 9.20e-03 | 1.52e-01 |
| CHOL | cg25693769 | chr3:33219620 | CGI:chr3:33218427-33219271 | promoter | 7.06e-01 | 4.45e-01 | 3.10e+00 | 1.96e-03 | 1.07e-02 | 2.61e-01 |
| CHOL | cg07008600 | chr3:33219712 | CGI:chr3:33218427-33219271 | promoter | 7.17e-01 | 4.42e-01 | 2.58e+00 | 9.87e-03 | 2.15e-02 | 2.75e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg13601427 | chr3:33219260 | CGI:chr3:33218427-33219271 | promoter | 1.88e-01 | 2.62e-02 | 1.19e+01 | 2.11e-32 | 4.18e-31 | 1.62e-01 |
| BRCA | cg04545136 | chr3:33219240 | CGI:chr3:33218427-33219271 | promoter | 2.87e-01 | 8.35e-02 | 1.06e+01 | 3.67e-26 | 3.49e-25 | 2.04e-01 |
| BRCA | cg02239862 | chr3:33219251 | CGI:chr3:33218427-33219271 | promoter | 3.45e-01 | 1.18e-01 | 1.14e+01 | 2.62e-30 | 3.96e-29 | 2.27e-01 |
| BRCA | cg03497399 | chr3:33219442 | CGI:chr3:33218427-33219271 | promoter | 7.55e-01 | 6.25e-01 | 8.31e+00 | 9.78e-17 | 4.07e-16 | 1.29e-01 |
| BRCA | cg25693769 | chr3:33219620 | CGI:chr3:33218427-33219271 | promoter | 7.93e-01 | 6.36e-01 | 1.11e+01 | 1.57e-28 | 1.92e-27 | 1.57e-01 |
| BRCA | cg07008600 | chr3:33219712 | CGI:chr3:33218427-33219271 | promoter | 6.64e-01 | 7.79e-01 | -6.75e+00 | 1.45e-11 | 4.06e-11 | -1.15e-01 |
| HNSC | cg26298814 | chr3:33218397 | CGI:chr3:33218427-33219271 | promoter,gene body | 1.82e-01 | 5.10e-02 | 2.54e+00 | 1.09e-02 | 1.95e-02 | 1.31e-01 |
| HNSC | cg07008600 | chr3:33219712 | CGI:chr3:33218427-33219271 | promoter | 6.08e-01 | 7.16e-01 | -2.17e+00 | 2.99e-02 | 3.54e-02 | -1.09e-01 |
| LIHC | cg25693769 | chr3:33219620 | CGI:chr3:33218427-33219271 | promoter | 6.01e-01 | 4.66e-01 | 2.17e+00 | 3.00e-02 | 3.33e-02 | 1.35e-01 |
| KIRP | cg03497399 | chr3:33219442 | CGI:chr3:33218427-33219271 | promoter | 5.51e-01 | 3.97e-01 | 2.33e+00 | 2.00e-02 | 2.67e-02 | 1.54e-01 |
Top |
Exon skipping events with PSI in TCGA for SUSD5 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for SUSD5 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for SUSD5 |
| TFs related to SUSD5. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | PRDM6 | SUSD5 | 2.78e+00 | 3.59e-03 | 3.85e+00 | 9.81e-01 | Female-biased |
| ACC | ZNF182 | SUSD5 | 2.83e+00 | 2.86e-03 | 3.95e+00 | 9.84e-01 | Female-biased |
| ACC | ZNF22 | SUSD5 | 2.82e+00 | 2.60e-03 | 3.97e+00 | 9.85e-01 | Female-biased |
| ACC | ZNF225 | SUSD5 | 2.79e+00 | 2.48e-03 | 3.95e+00 | 9.85e-01 | Female-biased |
| ACC | ZNF235 | SUSD5 | 3.03e+00 | 4.20e-03 | 4.07e+00 | 9.85e-01 | Female-biased |
| ACC | ZNF287 | SUSD5 | 2.97e+00 | 3.95e-03 | 4.02e+00 | 9.85e-01 | Female-biased |
| ACC | ZNF492 | SUSD5 | 2.95e+00 | 3.76e-03 | 4.01e+00 | 9.85e-01 | Female-biased |
| ACC | ZNF613 | SUSD5 | 2.87e+00 | 4.37e-03 | 3.89e+00 | 9.81e-01 | Female-biased |
| ACC | ZNF98 | SUSD5 | 2.85e+00 | 3.20e-03 | 3.95e+00 | 9.84e-01 | Female-biased |
| PAAD | MEF2A | SUSD5 | 4.17e+00 | 9.80e-01 | 3.30e+00 | 8.18e-03 | Male-biased |
| SKCM | PLAG1 | SUSD5 | 2.67e+00 | 1.15e-03 | 4.30e+00 | 9.81e-01 | Female-biased |
| SKCM | ZNF264 | SUSD5 | 3.03e+00 | 1.62e-03 | 4.57e+00 | 9.86e-01 | Female-biased |
| SKCM | ZNF337 | SUSD5 | 4.90e+00 | 9.80e-01 | 3.94e+00 | 1.28e-02 | Male-biased |
| SKCM | ZNF433 | SUSD5 | 5.20e+00 | 9.84e-01 | 4.20e+00 | 1.17e-02 | Male-biased |
| SKCM | ZNF454 | SUSD5 | 2.90e+00 | 1.83e-03 | 4.41e+00 | 9.83e-01 | Female-biased |
| UVM | MEF2A | SUSD5 | 2.68e+00 | 3.03e-03 | 4.54e+00 | 9.83e-01 | Female-biased |
| UVM | ZNF433 | SUSD5 | 4.37e+00 | 1.64e-02 | 5.43e+00 | 9.80e-01 | Female-biased |
| SUSD5 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for SUSD5 |
| RBPs related to ES in SUSD5. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| SUSD5 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000173705 | LINC02274,hsa-mir-543,SUSD5 | Male-specific ceRNA | TCGA-LUSC |
| ENSG00000173705 | HAND2-AS1,hsa-mir-6875,SUSD5 | Male-specific ceRNA | TCGA-LUSC |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs9813185 | chr3:29514485:C:A | - | 0.106789470421979 | 0.0185112992181073 | PCPG | Female-baised eQTL |
| rs9813186 | chr3:29514491:C:T | - | 0.106789470421979 | 0.0185112992181073 | PCPG | Female-baised eQTL |
| rs28729767 | chr3:29514857:C:T | - | 0.106789470421979 | 0.0185112992181073 | PCPG | Female-baised eQTL |
| rs28489737 | chr3:29514862:C:T | - | 0.106789470421979 | 0.0185112992181073 | PCPG | Female-baised eQTL |
| rs11709145 | chr3:35121969:C:A | - | 0.137719653440639 | 0.0277272404888785 | PCPG | Female-baised eQTL |
| rs6549882 | chr3:28728334:G:T | - | -0.139835468665577 | 0.0280760736268216 | PCPG | Female-baised eQTL |
| rs61280581 | chr3:37643946:G:A | - | 0.0613434030280659 | 0.0157210504673043 | THCA | Female-baised eQTL |
| rs76231171 | chr3:37633975:G:A | - | 0.061267619663434 | 0.0161551714720284 | THCA | Female-baised eQTL |
| rs113520526 | chr3:37637159:A:G | - | 0.0596306585868409 | 0.0256619886576608 | THCA | Female-baised eQTL |
| rs77996743 | chr3:35742407:T:G | - | 0.174390612398799 | 0.00182969898977368 | SARC | Female-baised eQTL |
| rs77402742 | chr3:39256082:G:A | - | 0.0655380786981784 | 0.000764992933570996 | LUAD | Female-baised eQTL |
| rs75540383 | chr3:39258985:T:C | - | 0.0655380786981784 | 0.000764992933570996 | LUAD | Female-baised eQTL |
| rs17038647 | chr3:39263097:T:C | - | 0.0655007604473322 | 0.000777890387904864 | LUAD | Female-baised eQTL |
| rs77430201 | chr3:39256698:A:G | - | 0.0654840861984804 | 0.0007821292452592 | LUAD | Female-baised eQTL |
| rs144968136 | chr3:39256944:C:T | - | 0.0654840861984804 | 0.0007821292452592 | LUAD | Female-baised eQTL |
| rs111678311 | chr3:39257042:A:G | - | 0.0654840861984804 | 0.0007821292452592 | LUAD | Female-baised eQTL |
| rs142929778 | chr3:39257062:G:A | - | 0.0654840861984804 | 0.0007821292452592 | LUAD | Female-baised eQTL |
| rs151081493 | chr3:39257065:A:T | - | 0.0654840861984804 | 0.0007821292452592 | LUAD | Female-baised eQTL |
| rs141003286 | chr3:39257075:T:A | - | 0.0654840861984804 | 0.0007821292452592 | LUAD | Female-baised eQTL |
| rs80077050 | chr3:39257235:G:A | - | 0.0654840861984804 | 0.0007821292452592 | LUAD | Female-baised eQTL |
| rs17038663 | chr3:39263813:C:T | - | 0.0603072901446974 | 0.00213202548436276 | LUAD | Female-baised eQTL |
| rs73038411 | chr3:24534703:A:T | - | 0.0507897133913077 | 0.00341246513141323 | LUAD | Female-baised eQTL |
| rs2196436 | chr3:24556525:A:G | - | 0.0485537830451384 | 0.0051655933052561 | LUAD | Female-baised eQTL |
| rs28436583 | chr3:36450566:C:T | - | 0.0561214373916461 | 0.00876897090382634 | LUAD | Female-baised eQTL |
| rs6550276 | chr3:34442280:A:G | - | -0.0592046072648729 | 0.0180114405583162 | LUAD | Female-baised eQTL |
| rs61577652 | chr3:34448404:C:T | - | -0.0585481269917509 | 0.0181122167470747 | LUAD | Female-baised eQTL |
| rs58534075 | chr3:34448406:T:G | - | -0.0585481269917509 | 0.0181122167470747 | LUAD | Female-baised eQTL |
| rs7648539 | chr3:34441670:T:A | - | -0.0584786354641913 | 0.0183788342325502 | LUAD | Female-baised eQTL |
| rs13082789 | chr3:31725536:G:A | - | 0.0496000645403918 | 0.0234656941100992 | LUAD | Female-baised eQTL |
| rs7614078 | chr3:34555717:T:C | - | -0.0536312789823682 | 0.0237462245094795 | LUAD | Female-baised eQTL |
| rs4678685 | chr3:34448736:A:G | - | -0.0571812987809394 | 0.0237873358758996 | LUAD | Female-baised eQTL |
| rs1609401 | chr3:34449955:C:T | - | -0.0571812987809394 | 0.0237873358758996 | LUAD | Female-baised eQTL |
| rs1609402 | chr3:34453858:G:A | - | -0.0571812987809394 | 0.0237873358758996 | LUAD | Female-baised eQTL |
| rs4676619 | chr3:39246468:G:A | - | -0.0498197462470698 | 0.029955395538661 | LUAD | Female-baised eQTL |
| rs73038427 | chr3:24538691:C:T | - | 0.0398139440635512 | 0.0300893476161654 | LUAD | Female-baised eQTL |
| rs4611761 | chr3:39245700:T:C | - | -0.0489683908378624 | 0.0329739407696204 | LUAD | Female-baised eQTL |
| rs9853927 | chr3:24551883:C:A | - | 0.0365511555099631 | 0.036770660240896 | LUAD | Female-baised eQTL |
| rs6550282 | chr3:34554870:A:G | - | -0.0495238180185645 | 0.0417932983485269 | LUAD | Female-baised eQTL |
| rs35052325 | chr3:39130185:C:T | - | 0.0434774555892716 | 0.0425672632521789 | LUAD | Female-baised eQTL |
| rs2336652 | chr3:34477849:A:C | - | -0.0494952576733649 | 0.0487627838954024 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs80020258 | chr3:25583313:T:G | - | 0.0580950209737123 | 0.0407767639625112 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000173705 |
| CpG Site: cg03497399 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.476061532014841 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg03497399 | chr3:33219442 | promoter | -0.476061532014841 | 1.67190942547457e-30 | -0.6729887394517345 | 5.419491065319312e-35 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of SUSD5 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
